Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2008
10/09/2008US20080248020 Variant lyase for use in treatment and prevention of cell proliferative disorders
10/09/2008US20080248019 Hydrolase which utilizes linkage-specific cleavage of galactose as part of therapeutic regimen for treatment of cell proliferative disorders; antitumor agents
10/09/2008US20080248018 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders
10/09/2008US20080248017 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive
10/09/2008US20080248016 Novel Iaccase Enzymes and Their Uses
10/09/2008US20080248014 Animal Medicament and Method of Manufacture
10/09/2008US20080248010 Protein kinase for use as tool in identifying modulators for treatment of diabetes
10/09/2008US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders
10/09/2008US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders
10/09/2008US20080247999 Cyclin dependent kinase-4 (CDK-4) peptides for use in treatment of cell proliferative disorders; antitumor agents
10/09/2008US20080247996 Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
10/09/2008US20080247992 N-Carboxyalkyl-1-cyclohexyl-2-substituted phenylbenzimidazole-5-carboxamides (2-[(1-cyclohexyl-2-{2-fluoro-4-[3-(aminocarbonyl)-6-(4-chlorophenyl)benzyloxy]-phenyl}-1H-benzimidazole-5-carbonyl)-amino]-3-(5-hydroxy-1H-indol-3-yl)-propionic acid); Flavivirus family infections such as hepatitus C
10/09/2008US20080247991 Solution Additives For the Attenuation of Protein Aggregation
10/09/2008US20080247990 Recombinant lymphocyte expressing CD16 receptor for use in targeting and destroying viral infection and tumor tissues
10/09/2008US20080247989 Using mushroom extract to propagate dendritic and chondrocytes cells for use in treatment of bone, cell proliferative and nervous system disorders
10/09/2008US20080247985 Composition base containing solubilized allantoin and urea for topical preparations
10/09/2008US20080247958 Prevents tissue injuries in mammals; hypovolemic conditions such as capillary leak syndrome and shock
10/09/2008US20080247956 Identification of novel factors that block programmed cell death or apoptosis by targeting jnk
10/09/2008US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008US20080247945 Interleukins; cytokines; monoclonal antibodies; bioconjugation; toxic shock syndrome
10/09/2008CA2683217A1 Compositions for nasal delivery
10/09/2008CA2682580A1 A method of modulating the activity of a nucleic acid molecule
10/09/2008CA2682569A1 Fusion proteins with cleavable spacers and uses thereof
10/09/2008CA2682521A1 Methods and compositions for the treatment of proliferative diseases
10/09/2008CA2682469A1 Method of treating ischemic disorders
10/09/2008CA2682444A1 Phage receptor binding proteins for antibacterial therapy and other novel uses
10/09/2008CA2682370A1 Process for the manufacture of a dairy-based anti-inflammatory composition
10/09/2008CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants
10/09/2008CA2681935A1 Treatment of obesity
10/09/2008CA2681828A1 Protein product for treatment of infectious diseases and related inflammatory processes
10/09/2008CA2681565A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978108A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978095A1 Chimeric receptor proteins for controlling signal transduction and ligands binding thereto
10/08/2008EP1978033A2 Human antibodies derived from immunized xenomice
10/08/2008EP1978031A2 Tropoelastin derivatives
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1978026A1 Novel t-helper antigenic determinant (thd) peptides
10/08/2008EP1978025A1 Novel kappa receptor selective opioid peptides
10/08/2008EP1977767A1 Method for in vivo regulation of cardiac muscle contractility
10/08/2008EP1977762A1 Ctgf as target for the therapy of diabetic nephropathy
10/08/2008EP1977760A2 Method for Treating Cervical Cancer
10/08/2008EP1977759A1 Pharmaceutical composition comprising a cytokine
10/08/2008EP1977758A2 Stem cell derived factors for treating pathologic conditions
10/08/2008EP1977747A1 Adaptive cardiac remodeling by beta-catenin downregulation
10/08/2008EP1976977A2 Placental stem cell populations
10/08/2008EP1976876A1 Process for the production of preformed conjugates of albumin and a therapeutic agent
10/08/2008EP1976865A1 Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium
10/08/2008EP1976863A1 Cyclic antimicrobial peptides
10/08/2008EP1976862A2 Novel peptides and the biological use thereof
10/08/2008EP1976596A2 Anti-viral griffithsin compounds, compositions, and methods of use
10/08/2008EP1976553A2 Compositions and methods for oxalate reduction
10/08/2008EP1976552A2 Protein kinase modulation by hops and acacia products
10/08/2008EP1976551A2 Compositions comprising polycation-complexed protein crystals and methods of treatment using them
10/08/2008EP1976550A2 Identification of apoptosis inducing proteins
10/08/2008EP1976549A2 Endothelin receptors in morphine withdrawal
10/08/2008EP1976548A1 Vip fragments and methods of use
10/08/2008EP1976547A1 R-ras activity in vascular regulation
10/08/2008EP1976545A1 Anticancer agent comprising a peptide
10/08/2008EP1976535A2 Treatment of acute respiratory distress syndrome
10/08/2008EP1976529A2 Ang2 and vegf inhibitor combinations
10/08/2008EP1833978B1 Tripeptide and tetrapeptide thioethers
10/08/2008EP1833842B1 Tripeptide and tetrapeptide sulfones
10/08/2008EP1809654B1 Heterocyclyl-substituted nonadepsipeptides
10/08/2008EP1784423B1 Novel peptide and pharmaceutical composition containing said peptide
10/08/2008EP1781596B1 Amino acid derived prodrugs of propofol compositions and uses thereof
10/08/2008EP1755634B1 Oligopeptides for reducing elevated blood urea concentration
10/08/2008EP1660493B1 Peptidyl heterocyclic ketone derivatives and preparation processes
10/08/2008EP1641486A4 Stable, aqueous solution of human erythropoietin, not containing serum albumin
10/08/2008EP1611247B1 Cyp2s1 as target for diagnosis and therapy of skin diseases
10/08/2008EP1511466B1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
10/08/2008EP1509546B1 Method for producing collagen
10/08/2008EP1507795B1 Tumour-associated peptides that bond to mhc molecules
10/08/2008EP1485346B1 Novel positively charged lipids and liposomes comprising the positively charged lipids
10/08/2008EP1465521A4 System and method for the pretreatment of the endplates of an intervertebral disc
10/08/2008EP1390059B1 Improved neuronal gene transfer
10/08/2008EP1390052A4 Inhibition of jun kinase
10/08/2008EP1370298B1 Elongated and multiple spacers in activatible prodrugs
10/08/2008EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer
10/08/2008EP1320589B1 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
10/08/2008EP1262548B1 Polypeptide inducing apoptosis
10/08/2008EP1189626B1 Composition for preventing tumoral growth
10/08/2008EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/08/2008EP1137762B1 Treatment of pompe's disease
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1044015B1 Formulations for amylin agonist peptides with insulin
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008EP0804580B1 Calcium binding recombinant antibody against protein c
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101282989A Method for diagnosticating rheumatic diseases
10/08/2008CN101282978A Macrocylic inhibitors of hepatitis c virus
10/08/2008CN101282763A Milk derived composition and use to enhance muscle mass or muscle strength
10/08/2008CN101282742A Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
10/08/2008CN101282741A Method for treating or preventing ischemia reperfusion injury or multi-organ failure
10/08/2008CN101282740A Treatment of optic neuritis
10/08/2008CN101282739A Therapeutic uses of artificial nanostructures
10/08/2008CN101282738A Analogs of ghrelin
10/08/2008CN101282736A Composition of whey growth factor extract for reducing muscle inflammation
1 ... 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 ... 3163